Cognitive impairment and cardiovascular disease related to alexithymia in a well-controlled HIV-infected population

Nicoletta Ciccarelli, Eleonora Baldonero, Benedetta Milanini, Massimiliano Fabbiani, Roberto Cauda, Simona Di Giambenedetto, Maria Caterina Silveri

Research output: Contribution to journalArticle

Abstract

Both cognitive diseases and alexithymia may be associated with HIV. Moreover, alexithymia has been linked to cardiovascular (CV) diseases. Our aim was to explore the prevalence of alexithymia and its associations with neurocognitive disorders (HAND) and CV risk factors in a well-controlled HIV-positive population. We consecutively enrolled 140 HIV-positive individuals on antiretroviral therapy and 35 healthy subjects matched for age, education and gender. In all participants alexithymia was explored by the 20-item Toronto Alexithymia Scale. For HIV-positive subjects also data about CV risk factors were collected, and a comprehensive neuropsychological examination was administered; HAND was defined according to Frascati criteria. Patients and controls did not differ in the proportion of alexithymic status (10% vs. 11%; p=0.761). Among HIV-positive patients, alexithymic participants presented a higher prevalence of diabetes (21% vs. 3%, p=0.035) and hypertension (36% vs. 13%, p= 0.037) compared to non-alexithymic. About 30% (n=41) of HIV-positive patients met criteria for asymptomatic HAND. Alexithymia was not independently associated with a higher risk of HAND (p=0.189). Analyzing each cognitive domain, alexithymia showed an independent association with an abnormal performance (OR 1.08; p=0.037) only in psychomotor speed. In conclusion, in the context of a well-controlled HIV infection, we found a low prevalence of alexithymia comparable to healthy controls. Alexithymia was linked to higher risk of CV disease in the HIV-positive population, but with a rate similar to that previously estimated in the HIV-negative alexithymic. Finally, alexithymia was clearly associated to cognitive impairment only in the psychomotor speed domain, suggesting a common fronto-striatal system dysregulation.

Original languageEnglish
Pages (from-to)274-282
Number of pages9
JournalLe infezioni in medicina
Volume27
Issue number3
Publication statusPublished - Sep 1 2019

Fingerprint

Affective Symptoms
Cardiovascular Diseases
HIV
Population
Cognitive Dysfunction
Corpus Striatum
HIV Infections
Healthy Volunteers
Hypertension
Education

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Ciccarelli, N., Baldonero, E., Milanini, B., Fabbiani, M., Cauda, R., Di Giambenedetto, S., & Silveri, M. C. (2019). Cognitive impairment and cardiovascular disease related to alexithymia in a well-controlled HIV-infected population. Le infezioni in medicina, 27(3), 274-282.

Cognitive impairment and cardiovascular disease related to alexithymia in a well-controlled HIV-infected population. / Ciccarelli, Nicoletta; Baldonero, Eleonora; Milanini, Benedetta; Fabbiani, Massimiliano; Cauda, Roberto; Di Giambenedetto, Simona; Silveri, Maria Caterina.

In: Le infezioni in medicina, Vol. 27, No. 3, 01.09.2019, p. 274-282.

Research output: Contribution to journalArticle

Ciccarelli, N, Baldonero, E, Milanini, B, Fabbiani, M, Cauda, R, Di Giambenedetto, S & Silveri, MC 2019, 'Cognitive impairment and cardiovascular disease related to alexithymia in a well-controlled HIV-infected population', Le infezioni in medicina, vol. 27, no. 3, pp. 274-282.
Ciccarelli N, Baldonero E, Milanini B, Fabbiani M, Cauda R, Di Giambenedetto S et al. Cognitive impairment and cardiovascular disease related to alexithymia in a well-controlled HIV-infected population. Le infezioni in medicina. 2019 Sep 1;27(3):274-282.
Ciccarelli, Nicoletta ; Baldonero, Eleonora ; Milanini, Benedetta ; Fabbiani, Massimiliano ; Cauda, Roberto ; Di Giambenedetto, Simona ; Silveri, Maria Caterina. / Cognitive impairment and cardiovascular disease related to alexithymia in a well-controlled HIV-infected population. In: Le infezioni in medicina. 2019 ; Vol. 27, No. 3. pp. 274-282.
@article{64b26b4353314598bb4d0346d8e94705,
title = "Cognitive impairment and cardiovascular disease related to alexithymia in a well-controlled HIV-infected population",
abstract = "Both cognitive diseases and alexithymia may be associated with HIV. Moreover, alexithymia has been linked to cardiovascular (CV) diseases. Our aim was to explore the prevalence of alexithymia and its associations with neurocognitive disorders (HAND) and CV risk factors in a well-controlled HIV-positive population. We consecutively enrolled 140 HIV-positive individuals on antiretroviral therapy and 35 healthy subjects matched for age, education and gender. In all participants alexithymia was explored by the 20-item Toronto Alexithymia Scale. For HIV-positive subjects also data about CV risk factors were collected, and a comprehensive neuropsychological examination was administered; HAND was defined according to Frascati criteria. Patients and controls did not differ in the proportion of alexithymic status (10{\%} vs. 11{\%}; p=0.761). Among HIV-positive patients, alexithymic participants presented a higher prevalence of diabetes (21{\%} vs. 3{\%}, p=0.035) and hypertension (36{\%} vs. 13{\%}, p= 0.037) compared to non-alexithymic. About 30{\%} (n=41) of HIV-positive patients met criteria for asymptomatic HAND. Alexithymia was not independently associated with a higher risk of HAND (p=0.189). Analyzing each cognitive domain, alexithymia showed an independent association with an abnormal performance (OR 1.08; p=0.037) only in psychomotor speed. In conclusion, in the context of a well-controlled HIV infection, we found a low prevalence of alexithymia comparable to healthy controls. Alexithymia was linked to higher risk of CV disease in the HIV-positive population, but with a rate similar to that previously estimated in the HIV-negative alexithymic. Finally, alexithymia was clearly associated to cognitive impairment only in the psychomotor speed domain, suggesting a common fronto-striatal system dysregulation.",
author = "Nicoletta Ciccarelli and Eleonora Baldonero and Benedetta Milanini and Massimiliano Fabbiani and Roberto Cauda and {Di Giambenedetto}, Simona and Silveri, {Maria Caterina}",
year = "2019",
month = "9",
day = "1",
language = "English",
volume = "27",
pages = "274--282",
journal = "Infezioni in Medicina",
issn = "1124-9390",
publisher = "EDIMES Edizioni Medico Scientifiche",
number = "3",

}

TY - JOUR

T1 - Cognitive impairment and cardiovascular disease related to alexithymia in a well-controlled HIV-infected population

AU - Ciccarelli, Nicoletta

AU - Baldonero, Eleonora

AU - Milanini, Benedetta

AU - Fabbiani, Massimiliano

AU - Cauda, Roberto

AU - Di Giambenedetto, Simona

AU - Silveri, Maria Caterina

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Both cognitive diseases and alexithymia may be associated with HIV. Moreover, alexithymia has been linked to cardiovascular (CV) diseases. Our aim was to explore the prevalence of alexithymia and its associations with neurocognitive disorders (HAND) and CV risk factors in a well-controlled HIV-positive population. We consecutively enrolled 140 HIV-positive individuals on antiretroviral therapy and 35 healthy subjects matched for age, education and gender. In all participants alexithymia was explored by the 20-item Toronto Alexithymia Scale. For HIV-positive subjects also data about CV risk factors were collected, and a comprehensive neuropsychological examination was administered; HAND was defined according to Frascati criteria. Patients and controls did not differ in the proportion of alexithymic status (10% vs. 11%; p=0.761). Among HIV-positive patients, alexithymic participants presented a higher prevalence of diabetes (21% vs. 3%, p=0.035) and hypertension (36% vs. 13%, p= 0.037) compared to non-alexithymic. About 30% (n=41) of HIV-positive patients met criteria for asymptomatic HAND. Alexithymia was not independently associated with a higher risk of HAND (p=0.189). Analyzing each cognitive domain, alexithymia showed an independent association with an abnormal performance (OR 1.08; p=0.037) only in psychomotor speed. In conclusion, in the context of a well-controlled HIV infection, we found a low prevalence of alexithymia comparable to healthy controls. Alexithymia was linked to higher risk of CV disease in the HIV-positive population, but with a rate similar to that previously estimated in the HIV-negative alexithymic. Finally, alexithymia was clearly associated to cognitive impairment only in the psychomotor speed domain, suggesting a common fronto-striatal system dysregulation.

AB - Both cognitive diseases and alexithymia may be associated with HIV. Moreover, alexithymia has been linked to cardiovascular (CV) diseases. Our aim was to explore the prevalence of alexithymia and its associations with neurocognitive disorders (HAND) and CV risk factors in a well-controlled HIV-positive population. We consecutively enrolled 140 HIV-positive individuals on antiretroviral therapy and 35 healthy subjects matched for age, education and gender. In all participants alexithymia was explored by the 20-item Toronto Alexithymia Scale. For HIV-positive subjects also data about CV risk factors were collected, and a comprehensive neuropsychological examination was administered; HAND was defined according to Frascati criteria. Patients and controls did not differ in the proportion of alexithymic status (10% vs. 11%; p=0.761). Among HIV-positive patients, alexithymic participants presented a higher prevalence of diabetes (21% vs. 3%, p=0.035) and hypertension (36% vs. 13%, p= 0.037) compared to non-alexithymic. About 30% (n=41) of HIV-positive patients met criteria for asymptomatic HAND. Alexithymia was not independently associated with a higher risk of HAND (p=0.189). Analyzing each cognitive domain, alexithymia showed an independent association with an abnormal performance (OR 1.08; p=0.037) only in psychomotor speed. In conclusion, in the context of a well-controlled HIV infection, we found a low prevalence of alexithymia comparable to healthy controls. Alexithymia was linked to higher risk of CV disease in the HIV-positive population, but with a rate similar to that previously estimated in the HIV-negative alexithymic. Finally, alexithymia was clearly associated to cognitive impairment only in the psychomotor speed domain, suggesting a common fronto-striatal system dysregulation.

UR - http://www.scopus.com/inward/record.url?scp=85072573563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072573563&partnerID=8YFLogxK

M3 - Article

C2 - 31545771

AN - SCOPUS:85072573563

VL - 27

SP - 274

EP - 282

JO - Infezioni in Medicina

JF - Infezioni in Medicina

SN - 1124-9390

IS - 3

ER -